National Health Investors Inc (NHI)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $3.09B
Last updated: Nov 17, 2026 at 11:06 AM ET
National Health Investors Inc (NHI) Stock Forecast
National Health Investors (NHI) has an FFO per share estimate of $4.96 for 2026. Analysts expect EPS of $4.06 for the fiscal year ending Dec 31, 2026, on revenue of $457.28M. Of 8 analysts, 5 rate the stock Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 8 ratings average 2.38, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 63% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 5 | 62.5% |
| Hold | 3 | 37.5% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 8
Price Target
Analyst price targets are part of paid GNG plans. See plans
FFO Estimates
FFO per share is expected at $4.96 for 2026, up 4.6% from $4.74 in 2025, and at $5.19 for 2027, up 4.6%.
- FFO per share, 2026
- $4.96
- Estimate
- FFO per share, 2027
- $5.19
- Estimate
- Fiscal year ending Dec 31, 2026
- $4.06
- EPS consensus, revenue $457.28M
- Next report
- Feb 24, 2027
- Estimated
| Fiscal year | Basis | FFO per share | Change |
|---|---|---|---|
| 2025 | Actual | $4.74 | N/A |
| 2026 | Estimate | $4.96 | +4.6% |
| 2027 | Estimate | $5.19 | +4.6% |
Annual Estimates
From the first fiscal year below to the second, the EPS consensus falls 15.0% and revenue estimates rise 6.7%.
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $4.06 | $3.38 to $4.68 | 4 | $457.28M | $447.65M to $473.28M | 5 |
| Dec 31, 2027 | $3.45 | $3.45 to $3.45 | 1 | $487.73M | $467.79M to $514.46M | 5 |
Quarterly Estimates
The EPS consensus rises from $0.72 for the quarter ending Dec 31, 2026 to $0.73 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.72 | $0.66 to $0.79 | 6 | $114.78M | $107.21M to $126.89M | 7 |
| Mar 31, 2027 | $0.73 | $0.73 to $0.73 | 1 | $116.15M | $109.64M to $123.96M | 5 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 2 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 7.7% from $3.77.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $4.06 | $4.06 | $3.89 | $4.19 | $3.77 | +7.7% |
| Fiscal year ending Dec 31, 2027 | $3.45 | $3.36 | $3.25 | $3.25 | $3.31 | +4.2% |
| Quarter ending Mar 31, 2027 | $0.73 | $0.75 | $0.75 | $0.75 | $0.75 | -2.7% |
Frequently Asked Questions About NHI
What is the NHI stock forecast?
National Health Investors's FFO per share estimate for 2026 is $4.96. Consensus analyst estimates put National Health Investors's EPS at $4.06 for the fiscal year ending Dec 31, 2026, on revenue of $457.28M. The consensus rating from 8 analysts is Buy.
How do analysts rate NHI stock?
Of 8 analysts covering National Health Investors, 0 rate it Strong Buy, 5 Buy, 3 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from NHI next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $4.06, with estimates from $3.38 to $4.68 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $3.45, with estimates from $3.45 to $3.45 from 1 analyst.
What revenue do analysts expect from National Health Investors next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $457.28M, with estimates from $447.65M to $473.28M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $487.73M, with estimates from $467.79M to $514.46M.
How many analysts cover NHI?
8 analysts rate National Health Investors stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
NHI pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors